Today on Outsourcing-Pharma.com   Pfizer partners in shock after surprise Exubera exit King trims its court following Altace about-turn Discarded body parts used to cut animal testing Pharma outsourcing: people on the move Study your rats so the results don't bite

Related Industry News   Viagra could cause hearing loss Aspirin won't protect women from a broken heart Pfizer counts the cost of Exubera, Nektar suffers Viracept back on the market in selected countries

Breaking News on Outsourcing Pharma
Daily  Monday 22 October 2007		Forward to a colleague

	Product Brochure Baxter's contract services case study Baxter's contract services case study details the expedited transfer of a commercial launched lyophilized drug to a new production site. Their team designed solutions resulting in cost savings, yield improvement and cycle optimization... Click Here Access Full Stories Pfizer partners in shock after surprise Exubera exit We've all cringed at stories of people dumping their partners via text message but in the world of business, Pfizer seems to have taken things to a new level when its Exubera partners were allegedly left to find... Read King trims its court following Altace about-turn King Pharmaceuticals last week announced that it would be cutting 20 per cent of its workforce after the US Court of Appeals reversed a previous court ruling and invalidated a patent covering the firm's blood pressure... Read Discarded body parts used to cut animal testing A team of US scientists have used typically discarded body parts to create a 'joint in a test tube', which they can use to test arthritis drugs instead of using animals... Read Pharma outsourcing: people on the move Icon, PPD, Chiltern, Kendle, Omnicare and Aesica have all had people on the move in the world of pharmaceutical outsourcing... Read Study your rats so the results don't bite New research has shown that even if laboratory rats are genetically identical they can still develop distinct metabolic profiles that could skew drug toxicity and metabolism studies... Read
	All News Headlines for: October | September | August
	Related Industry News Viagra could cause hearing loss The earth may move and the heavens may shake but drug regulators now think Viagra could also make you go deaf... Read Aspirin won't protect women from a broken heart While aspirin has been found to reduce the risk of heart attack by a quarter, recent research has found that women are less likely to benefit from the drug than men... Read Pfizer counts the cost of Exubera, Nektar suffers With yesterday's perhaps unsurprising news that Pfizer has cut its losses and pulled out of the inhaled insulin market by dropping Exubera and giving up on second generation devices, the world's biggest pharma... Read Viracept back on the market in selected countries Roche heard early this morning that the European Commission (EC) has decided to reinstate the marketing authorisation for the company's HIV drug, Viracept (nelfinavir), but countries outside the EU have yet to... Read Weekly Comment 'We are not anti-Asia' says EU chemicals body There have been more calls this month to tighten regulations on pharmaceutical ingredient suppliers in the wake of the recent safety concerns emanating from low-cost regions such as China and India.  However, despite having recently established a dedicated 'China Taskforce', a major EU chemicals consortium insists that it has nothing against the region or its manufacturers. Read Previous Headlines Industry bodies call for EU clinical trials directive changes Two major bioscience industry trade associations have called for changes to be made to the European clinical trials directive in order to bring about "harmonisation, transparency and consistency" in this area across... Read Pfizer abandons ship as Exubera sinks Pfizer revealed today that it is abandoning its once-touted blockbuster Exubera, ending months of speculation as to whether the fledging world-first inhalable insulin would sink or swim in the fierce waters of... Read Novartis suffers from generics, cuts jobs Novartis has turned in its results for the first nine months of the year, with income gnawed at by generic competition and product suspensions, but still claiming record earnings helped along by divestment gains... Read Online drug discovery services database to be launched A US start-up firm is gearing up to launch an online database where researchers can access a variety of drug discovery service providers across the globe... Read Big players boosting 3PL clout Three big industry names have been busily bolstering their pharma logistics clout: Thermo Fisher Scientific, UPS and Kuehne+Nagel... Read Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analytical testing, QC Bulk ingredients Contract sales & marketing Data management Drug delivery, formulation Fill & finish, packaging Phase I-II Phase III-IV Preclinical Product & Supplier News - Contract Manufacturing Regulatory affairs Supply chain, logistics Validation services

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@OutSourcing-Pharma.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com